Vaginalblødning blev set hos 74 (2, 6%) Fablyn- behandlede kvinder versus 37 (1, 3%) placebobehandlede kvinder.
Vaginal bleeding was reported in 74 (2.6%) FABLYN-treated women versus 37 (1.3%) placebo-treated women.